Handy Soft (220180) has 3 disclosed insider purchases and 0 disclosed disposals on record, filed by 2 distinct insiders. Together those filings cover ₩11M ($8K) in reported transaction value. The earliest filing StockDrifts holds for Handy Soft is dated 2020-04-07; the most recent is 2025-09-11. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is -30.33%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2025-09-11 | BUY | 제3자배정유상증자 | 폴라리스AI PolarisAI | - | 2.7M | ₩2,820 | -31.6% | ₩7.7B ($5.3M) |
| 2025-09-11 | BUY | 제3자배정유상증자 | 폴라리스세원 Polaris Sewon | - | 1.8M | ₩2,820 | -31.6% | ₩5.1B ($3.5M) |
| 2025-09-08 | BUY | 장외매수 | 폴라리스AI PolarisAI | - | 4.3M | ₩2,600 | -25.8% | ₩11.1B ($7.7M) |
| 2025-09-08 | BUY | 장외매수 | 폴라리스세원 Polaris Sewon | - | 2.9M | ₩2,600 | -25.8% | ₩7.4B ($5.2M) |
| 2025-09-08 | SELL | 장외매도 | 오상헬스케어 Osang Healthcare | - | -2.8M | ₩2,600 | +25.8% | ₩7.2B ($5.0M) |
| 2025-09-08 | SELL | 장외매도 | 오상 stigmata | - | -3.1M | ₩2,600 | +25.8% | ₩8.0B ($5.6M) |
| 2025-05-27 | BUY | Market Buy | 이상엽 Lee Sang-yeop | vice president | 7 | ₩2,420 | -20.3% | ₩17K ($12) |
| 2025-05-23 | BUY | Market Buy | 이상엽 Lee Sang-yeop | vice president | 3.8K | ₩2,515 | -23.3% | ₩9M ($7K) |
| 2024-05-17 | BUY | 기타 | 이상엽 Lee Sang-yeop | Managing Director | 3.3K | ₩4,060 | -52.5% | ₩13M ($9K) |
| 2024-05-14 | BUY | 기타 | 강철훈 Kang Cheol-hoon | Other non-executive directors | 2.4K | ₩4,135 | -53.3% | ₩10M ($7K) |
| 2020-04-07 | BUY | Market Buy | 오상 stigmata | - | 473 | ₩3,675 | -47.5% | ₩2M ($1K) |
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Handy Soft. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.